Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Abstract Background Breast cancer currently is the most frequently diagnosed neoplasm and the leading cause of death from cancer in women worldwide, which is mainly due to metastatic disease. Increasing our understanding of the molecular mechanisms leading to metastasis might thus improve the pharma...
Main Authors: | José Esparza-López, Juan Francisco Alvarado-Muñoz, Elizabeth Escobar-Arriaga, Alfredo Ulloa-Aguirre, María de Jesús Ibarra-Sánchez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5945-1 |
Similar Items
-
Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
by: Ling Li, et al.
Published: (2020-09-01) -
Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
by: Ekaterini Platanitis, et al.
Published: (2018-11-01) -
Metformin Improves Burn Wound Healing by Modulating Microenvironmental Fibroblasts and Macrophages
by: Liangliang Shi, et al.
Published: (2022-12-01) -
Metformin attenuates LPS-induced neuronal injury and cognitive impairments by blocking NF-κB pathway
by: Chenliang Zhou, et al.
Published: (2021-11-01) -
Adiponectin Suppresses Metastasis of Nasopharyngeal Carcinoma through Blocking the Activation of NF-κB and STAT3 Signaling
by: Zongmeng Zhang, et al.
Published: (2022-10-01)